Assessing Human Health-Correlation of Autoimmune Diseases with Chemically Suppressed Acute Infections of Patient’s Past Medical History
DOI:
https://doi.org/10.12970/2310-9874.2017.05.06Keywords:
Past history, fever, acute infections, autoimmunity, suppression, drugs, Immune system, Prognosis, Levels of Health, Continuum of diseases, Psychoneuroimmunology.Abstract
This is an effort to present to the medical profession, a new concept for evaluating the level of health of an individual, through the theory of Professor George Vithoulkas.
The theory of Levels of Health has proven to be a valuable aid to clinicians as it enables them not only to evaluate the patient’s health status, but also to adapt the course of individual treatment. This is achieved by assessing the body's response, to therapy of any kind. When coupled with the ‘Continuum of unified theory of diseases’, disease and treatment are better understood and provide a reference standard for clinicians.
The application of the concepts of Psychoneuroimmunology (PNI) and those correlating the suppression of acute diseases with simultaneous emergence of chronic conditions opens up new horizons in understanding the human body's nature in this respect. The treatment of acute diseases can lead in two opposite directions: it can either bring about a cure or, on the contrary, cause a gradual degeneration of the body's PNI defense.
With regard to ‘symptoms,’ their reduction or the disappearance following a treatment, is either because the body does not need them anymore, having reached a higher level of health or, that it cannot maintain them anymore, as its health has been degraded due to the treatment.
The ideal treatment should not simply eliminate the symptoms while the overall health deteriorates. Instead, it must aim at enhancing the action of the immune system in its own direction by strengthening the symptoms generated by it. This way the immune system becomes stronger after getting rid of the disease and the overall health becomes better.
References
Vithoulkas G. The science of homeopathy. Athens: A.S.O.H.M. 1978.
Vithoulkas G, Woensel E. Levels of health. Alonissos, Greece: International Academy of Classical Homeopathy 2010.
Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infection and Immunity 1999; 67(8): 3703-13.
Hart PD, Russell E, Remington JS. The compromised host and infection. II. Deep fungal infection. The Journal of Infectious Diseases 1969; 120(2): 169-91. https://doi.org/10.1093/infdis/120.2.169
Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Canadian Journal of Public Health 2001; 92(4): 281.
Hofstra AH, Li-Muller SM, Uetrecht JP. Metabolism of isoniazid by activated leukocytes. Possible role in drug-induced lupus. Drug Metabolism and Disposition 1992; 20(2): 205-10.
Kim SW, Grant JE, Kim SI, Swanson TA, Bernstein GA, Jaszcz WB, Williams KA, Schlievert PM. A possible association of recurrent streptococcal infections and acute onset of obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences 2004; 16(3): 252-60. https://doi.org/10.1176/jnp.16.3.252
Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity–friends or foes? Trends in Immunology 2009; 30(8): 409-14.
Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005; 38(3): 235-45. https://doi.org/10.1080/08916930500050277
Koutroubakis IE, Vlachonikolis IG, Kapsoritakis A, Spanoudakis S, Roussomoustakaki M, Mouzas IA, Kouroumalis EA, Manousos ON. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease. Diseases of the Colon & Rectum 1999; 42(2): 225-30. https://doi.org/10.1007/BF02237133
Ziemssen T, Kern S. Psychoneuroimmunology–cross-talk between the immune and nervous systems. Journal of Neurology 2007; 254: II8-11.
Maier SF, Watkins LR, Fleshner M. Psychoneuro-immunology: The interface between behavior, brain, and immunity. American Psychologist 1994; 49(12): 1004. https://doi.org/10.1037/0003-066X.49.12.1004
Autoimmune Info - American Autoimmune Related Diseases Association [Internet]. AARDA. 2017 [cited 5 June 2017]. Available from: https://www.aarda.org
Cooke A. Infection and autoimmunity. Blood Cells, Molecules, and Diseases 2009; 42(2): 105-7. https://doi.org/10.1016/j.bcmd.2008.10.004
Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. International Journal of Celiac Disease 2015; 3(4): 151-5. https://doi.org/10.12691/ijcd-3-4-8
Lipman TH, Katz LE, Ratcliffe SJ, Murphy KM, Aguilar A, Rezvani I, Howe CJ, Fadia S, Suarez E. Increasing incidence of type 1 diabetes in youth. Diabetes Care 2013; 36(6): 1597-603. https://doi.org/10.2337/dc12-0767
Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD. Rising incidence of inflammatory bowel disease among children: a 12-year study. Journal of Pediatric Gastroenterology and Nutrition 2010; 50(1): 27-31. https://doi.org/10.1097/MPG.0b013e3181b99baa
Casselbrant ML, Mandel EM, Doyle WJ. Information on co-morbidities collected by history is useful for assigning Otitis Media risk to children. International Journal of Pediatric Otorhinolaryngology 2016; 85: 136-40. https://doi.org/10.1016/j.ijporl.2016.03.040
MacIntyre EA, Heinrich J. Otitis media in infancy and the development of asthma and atopic disease. Current Allergy and Asthma Reports 2012; 12(6): 547-50. https://doi.org/10.1007/s11882-012-0308-x
Maté-Jimenez J, Correa-Estañ JA, Perez-Miranda M, Gomez-Cedenilla A, Pajares JM, Moreno-Otero R. Tonsillectomy and inflammatory bowel disease location. European Journal of Gastroenterology & Hepatology 1996; 8(12): 1185-888. https://doi.org/10.1097/00042737-199612000-00010
Schlehofer B, Blettner M, Preston‐Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J. Role of medical history in brain tumour development. Results from the international adult brain tumour study. International Journal of Cancer 1999; 82(2): 155-60. https://doi.org/10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P
Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012; 37(1): 137-62. https://doi.org/10.1038/npp.2011.205
Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272(5258): 54. https://doi.org/10.1126/science.272.5258.54
Bach JF. Infections and autoimmune diseases. Journal of Autoimmunity 2005; 25: 74-80. https://doi.org/10.1016/j.jaut.2005.09.024
Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. New England Journal of Medicine 2002; 347(12): 911-20. https://doi.org/10.1056/NEJMra020100
Bach JF. Six questions about the hygiene hypothesis. Cellular Immunology 2005; 233(2): 158-61. https://doi.org/10.1016/j.cellimm.2005.04.006
Cahoon EK, Inskip PD, Gridley G, Brenner AV. Immune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans. British Journal of Cancer 2014; 110(7): 1825-33. https://doi.org/10.1038/bjc.2014.97
Cooke A, Zaccone P, Raine T, Phillips JM, Dunne DW. Infection and autoimmunity: are we winning the war, only to lose the peace? Trends in Parasitology 2004; 20(7): 316-21.
Gaisford W, Cooke A. Can infections protect against autoimmunity? Current Opinion in Rheumatology 2009; 21(4): 391-6.
Okada H, Kuhn C, Feillet H, Bach JF. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clinical & Experimental Immunology 2010; 160(1): 1-9. https://doi.org/10.1111/j.1365-2249.2010.04139.x
van der Kleij D, Yazdanbakhsh M. Control of inflammatory diseases by pathogens: lipids and the immune system. European Journal of Immunology 2003; 33(11): 2953-63. https://doi.org/10.1002/eji.200324340
Burgess JA, Lowe AJ, Matheson MC, Varigos G, Abramson MJ, Dharmage SC. Does eczema lead to asthma? Journal of Asthma 2009; 46(5): 429-36.
Spergel JM. From atopic dermatitis to asthma: the atopic march. Annals of Allergy, Asthma & Immunology 2010; 105(2): 99-106. https://doi.org/10.1016/j.anai.2009.10.002
Vithoulkas G, Carlino S. The “continuum” of a unified theory of diseases. Med Sci Monit 2010; 16(2): 15.
O'connor TG, Moynihan JA, Caserta MT. Annual research review: the neuroinflammation hypothesis for stress and psychopathology in children–developmental psychoneuroimmunology. Journal of Child Psychology and Psychiatry 2014; 55(6): 615-31. https://doi.org/10.1111/jcpp.12187
Root-Bernstein R, Fairweather D. Complexities in the relationship between infection and autoimmunity. Current Allergy and Asthma Reports 2014; 14(1): 407. https://doi.org/10.1007/s11882-013-0407-3
Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host & Microbe 2015; 17(5): 565-76. https://doi.org/10.1016/j.chom.2015.04.011
Solomon GF. Psychoneuroimmunology: interactions between central nervous system and immune system. Journal of Neuroscience Research 1987; 18(1): 1-9. https://doi.org/10.1002/jnr.490180103
Sperner-Unterweger B. Biological hypotheses of schizophrenia: possible influences of immunology and endocrinology. Fortschritte der Neurologie-Psychiatrie 2005; 73: S38-43.
Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders. Drugs 2005; 65(11): 1493-520. https://doi.org/10.2165/00003495-200565110-00004
Riedel W, Maulik G. Fever: an integrated response of the central nervous system to oxidative stress. Molecular and Cellular Biochemistry 1999; 196(1): 125-32. https://doi.org/10.1023/A:1006936111474
Smith RS. The immune system is a key factor in the etiology of psychosocial disease. Medical Hypotheses 1991; 34(1): 49-57. https://doi.org/10.1016/0306-9877(91)90064-6
Stefferl A, Hopkins SJ, Rothwell NJ, Luheshi GN. The role of TNF‐α in fever: opposing actions of human and murine TNF‐α and interactions with IL‐β in the rat. British Journal of Pharmacology 1996; 118(8): 1919-24. https://doi.org/10.1111/j.1476-5381.1996.tb15625.x
Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Annals of Internal Medicine 1992; 117(10): 854-66. https://doi.org/10.7326/0003-4819-117-10-854
Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Elhaddad A, Lasko D, Amortegui J, Dy CJ, Dlugasch L, Baracco G. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surgical Infections 2005; 6(4): 369-75. https://doi.org/10.1089/sur.2005.6.369
Ackerman Z, Flugelman MY, Wax Y, Shouval D, Levy M. Hepatitis during measles in young adults: possible role of antipyretic drugs. Hepatology 1989; 10(2): 203-6. https://doi.org/10.1002/hep.1840100214
Su F, Nguyen ND, Wang Z, Cai Y, Rogiers P, Vincent JL. Fever control in septic shock: beneficial or harmful? Shock 2005; 23(6): 516-20.
de Bont EG, Brand PL, Dinant GJ, van Well GT, Cals J. Risks and benefits of paracetamol in children with fever. Nederlands Tijdschrift Voor Geneeskunde 2013; 158(2): A6636. https://doi.org/10.1093/fampra/cmv029
de Bont EG, Peetoom KK, Moser A, Francis NA, Dinant GJ, Cals JW. Childhood fever: a qualitative study on GPs’ experiences during out-of-hours care. Family Practice 2015; 32(4): 449-55.
Kelly M, McCarthy S, O’Sullivan R, Shiely F, Larkin P, Brenner M, Sahm LJ. Drivers for inappropriate fever management in children: a systematic review. International Journal of Clinical Pharmacy 2016; 38(4): 761-70. https://doi.org/10.1007/s11096-016-0333-2
Knoebel EE, Narang AS, Ey JL. Fever: to treat or not to treat. Clinical Pediatrics 2002; 41(1): 9-16. https://doi.org/10.1177/000992280204100104
Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatrics 2014; 168(11): 1063-9. https://doi.org/10.1001/jamapediatrics.2014.1539
Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156(1): 3216. https://doi.org/10.1099/mic.0.040618-0
Smith TW, Girolami UD, Hickey WF. Neuropathology of immunosuppression. Brain Pathology 1992; 2(3): 183-94. https://doi.org/10.1111/j.1750-3639.1992.tb00691.x
Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmunity Reviews 2002; 1(6): 329-37. https://doi.org/10.1016/S1568-9972(02)00086-1
Earn DJ, Andrews PW, Bolker BM. Population-level effects of suppressing fever. In Proc. R. Soc. B 2014 Mar 7 (Vol. 281, No. 1778, p. 20132570). The Royal Society.
Gündüz Ö. Immunomodulation with antibiotics. immunomodulatory and immunsuppressive drugs in dermatology 2016; 19.
Lee WM. Hepatitis B virus infection. New England Journal of Medicine 1997; 337(24): 1733-45. https://doi.org/10.1056/NEJM199712113372406
Torres AR. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatrics 2003; 3(1): 9.
Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999; 99(2): 237-42. https://doi.org/10.1161/01.CIR.99.2.237
Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis A systematic review. Neurology 2008; 71(2): 129-35. https://doi.org/10.1212/01.wnl.0000316802.35974.34
World Health Organization (WHO. Atlas. Multiple sclerosis resources in the world, 2008. World Health Organization 2008.
Kivellos S, Skifti S, Vithoulkas G. EHMTI-0396. Reappearance of high fever on migraine patients, after individualized homeopathic treatment, is a valuable prognostic factor. The Journal of Headache and Pain 2014; 15(1): M7.
Curran LK, Newschaffer CJ, Lee LC, Crawford SO, Johnston MV, Zimmerman AW. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007; 120(6): e1386-92.
Megremi AS. Is fever a predictive factor in the autism spectrum disorders? Medical Hypotheses 2013; 80(4): 391-8.
Cann SH, Van Netten JP, Van Netten C. Dr William Coley and tumour regression: a place in history or in the future. Postgraduate Medical Journal 2003; 79(938): 672-80.
Mehler MF, Purpura DP. Autism, fever, epigenetics and the locus coeruleus. Brain Research Reviews 2009; 59(2): 388-92. https://doi.org/10.1016/j.brainresrev.2008.11.001
NIH funds study on why fever sometimes eases autism symptoms [Internet]. Autism Speaks. 2017 [cited 6 June 2017]. Available from: https://www.autismspeaks.org/ science/science-news/nih-funds-study-exploring-why-fever-sometimes-eases-autism-symptoms.
Chrousos GP, Gold PW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 1992; 267(9): 1244-52. https://doi.org/10.1001/jama.1992.03480090092034
Duff GW, Durum SK. Fever and immunoregulation: hyperthermia, interleukins 1 and 2, and T-cell proliferation. The Yale Journal of Biology and Medicine 1982; 55(5-6): 437.
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology. 2002; 53(1): 83-107. https://doi.org/10.1146/annurev.psych.53.100901.135217
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology: psychological influences on immune function and health. Journal of Consulting and Clinical Psychology 2002; 70(3): 537. https://doi.org/10.1037/0022-006X.70.3.537
Stub T, Salamonsen A, Alraek T. Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study. Forschende Komplementärmedizin/Research in Complementary Medicine 2012; 19(1): 13-9. https://doi.org/10.1159/000335827
Barak Y, Wohl Y, Greenberg Y, Dayan YB, Friedman T, Shoval G, Knobler HY. Affective psychosis following Accutane (isotretinoin) treatment. International Clinical Psychopharmacology 2005; 20(1): 39-41. https://doi.org/10.1097/00004850-200501000-00008
Bravard P, Krug M, Rzeznick JC. Isotretinoine et depression: soyons vigilants. Les Nouvelles Dermatologiques 1993; 12(4): 233-54.
Bremner JD, Shearer K, McCaffery P. Retinoic acid and affective disorders: the evidence for an association. The Journal of Clinical Psychiatry 2012; 73(1): 37. https://doi.org/10.4088/JCP.10r05993
